180 Life Sciences Initiates $156 Million Private Offering for Ethereum Growth Strategy

180 Life Sciences' New Funding Strategy: Expanding Ethereum Holdings

On August 11, 2025, 180 Life Sciences Corp., also known as ETHZilla, announced significant progress in its financing strategy by successfully closing a private offering that raised approximately $156 million through senior secured convertible notes. This noteworthy deal, which was completed on August 8, 2025, is part of a broader strategy aimed at significantly increasing the company’s holdings in Ethereum (ETH).

Financial Growth and Future Plans

The proceeds from this convertible note offering will primarily be utilized to bolster the company's ETH funds, further solidifying its position in the ever-evolving crypto landscape. The firm's Executive Chairman, McAndrew Rudisill, emphasized that this financial maneuver enhances the company’s balance sheet and provides a robust foundation for their ETH treasury strategy. This approach aligns with the company’s long-term vision of creating a dynamic accumulation vehicle centered around Ethereum.

Prior to this offering, the company had already garnered attention by concluding a $425 million private placement which set the stage for their ambitions in the digital asset space. The strategy is underpinned by a commitment to transparency, and 180 Life Sciences plans to provide regular updates on their Ethereum holdings to establish trust with investors.

Convertible Notes: Key Details

The newly issued convertible notes will not accrue interest for the first six months, after which a 4% annual interest rate will apply. These notes are set to mature three years from the issuance date, though they can be converted into common stock at the option of the holder at a specified price of $3.445 per share. The terms also include a provision for a potential price adjustment, ensuring that investors retain their rights in fluctuating market conditions.

Interestingly, from the six-month mark onwards, the company can compel noteholders to convert their notes into stock, although certain conditions must be met first.

Diverse Financial Activities

The total proceeds from both the PIPE offering and the current convertible notes will support various initiatives: augmenting their Ethereum assets, investing in yield-bearing options, and continuing existing operations in the iGaming industry. Additionally, the company aims to monetize its legacy biotechnology intellectual property, ensuring the effective use of its capital.

180 Life Sciences: A New Direction

As part of an innovative pivot, 180 Life Sciences is evolving from its traditional biotechnology roots towards a more technology-driven gaming and entertainment focus. Their rebranding to ETHZilla Corporation reflects this shift, which is packaged with a comprehensive ETH treasury management strategy aimed at setting benchmarks for public companies engaging in digital asset management.

In its pursuit of growth, the firm has enlisted the expertise of a seasoned executive team and a decentralized finance (DeFi) council comprising capital market specialists, prominent Ethereum developers, and notable founders from the DeFi ecosystem. This collective expertise is expected to reinforce the company’s endeavors in enhancing Ethereum integration and yield generation strategies that exceed traditional staking methods.

Looking Ahead

As 180 Life Sciences ventures into this new chapter, the company remains aware of the inherent risks associated with cryptocurrency investments. Market volatility, regulatory changes, and competitive pressures pose challenges that could impact their operations and investment outcomes. However, the company is committed to advancing its mission and fulfilling its outlined goals.

Investors and stakeholders have closely followed 180 Life Sciences' developments, eager to witness how the combination of traditional biotech aspirations and cutting-edge digital asset strategies plays out in the rapidly changing economic arena. The next few years hold promise as the company adapts to and thrives in its new operational paradigm, reflecting the transformative potential of blockchain technologies.